Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Management of mineral metabolism in haemodialysis patients: need for new strategies

European Journal of Clinical Nutrition volume 68, pages 859–860 (2014)Cite this article

Subjects

We read with great interest the paper by Collinson et al.1 recently published in the European Journal of Clinical Nutrition.

The authors investigated the reasons for the high failure rate in preventing hyperphosphataemia in haemodialysis patients (HD).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Collinson A, McMullan M, Tse WY, Sadler H . Managing serum phosphate in haemodialysis patients: time for an innovative approach? Eur J Clin Nutr 2014; 68: 392–396.

    Article  CAS  Google Scholar 

  2. Charlson M, Szatrowski TP, Peterson J, Gold J . Validation of a combined comorbidity index. Clin Epidemiol 1994; 47: 1245–1251.

    Article  CAS  Google Scholar 

  3. Fouque D, Roth H, Pelletier S, London GM, Hannedouche T, Jean G et al. Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets? Nephrol Dial Transplant. 2013; 28: 360–367.

    Article  CAS  Google Scholar 

  4. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis 2003; 42: S1–S201.

    Google Scholar 

  5. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease- Mineral and Bone Disorder (CKD-MBD). Kidney Int 2009; 76: S1–S130.

    Google Scholar 

  6. Arenas MD, Malek T, Gil MT, Moledous A, Alvarez-Ude F, Reig-Ferrer A . Challenge of phosphorus control in hemodialysis patients: a problem of adherence? J Nephrol 2010; 23: 525–534.

    PubMed  Google Scholar 

  7. Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004; 44: 34–38.

    Article  Google Scholar 

  8. Uhlig K, Berns JS, Kestenbaum B, Kumar R, Leonard MB, Martin KJ et al. KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis 2010; 55: 773–799.

    Article  Google Scholar 

  9. Kuhlmann MK, Hoechst S, Landthaler I . Patient empowerment in the management of hyperphosphatemia. Int J Artif Organs 2007; 30: 1008–1013.

    Article  CAS  Google Scholar 

  10. Russell CL, Cronk NJ, Herron M, Knowles N, Matteson ML, Peace L et al. Motivational Interviewing in Dialysis Adherence Study (MIDAS). Nephrol Nurs J 2011; 38: 229–236.

    PubMed  Google Scholar 

  11. Kalanthar-Zadeh K . Patient education for phosphorus management in chronic kidney disease. Patient Prefer Adherence 2013; 7: 379–390.

    Article  Google Scholar 

Download references

Acknowledgements

We thank all our colleagues who were essential for data collection: G Pacchiano, F Mirenghi, R d’Amato, V Di Stasio, AR Oggero, G Marinelli, E De Felice R Scigliano, M Andretti, A Ciotola, C Evangelista, S Buglione, M Cioffi, F Cappabianca, G Correale, P Granato, L Ciaccia, S Vitiello, A De Donato, AD Ordonez, D Bonanno, M Pluvio, V De Marino, S Cesare, A Pitti, V Rossi V, F Della Grotta and F Principe.

Author information

Authors and Affiliations

  1. Department of Nephrology, Dialysis and Transplantation, Fondazione IRCCS Policlinico ‘San Matteo’ and University of Pavia, Pavia, Italy,

    P Esposito, T Rampino & A Dal Canton

  2. NephroCare Medical Direction, Naples, Italy

    A Di Benedetto

  3. NephroCare Coordination EMEALA, Bad Homburg, Germany

    S Stuard

  4. NephroCare EMEALA Medical Board, Bad Homburg, Germany

    D Marcelli & B Canaud

Authors
  1. P Esposito
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Di Benedetto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Rampino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Stuard
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D Marcelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. B Canaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. A Dal Canton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to P Esposito.

Ethics declarations

Competing interests

ADB, SS, DM and BC had financial relationships (employment) with NephroCare. The remaining authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Esposito, P., Di Benedetto, A., Rampino, T. et al. Management of mineral metabolism in haemodialysis patients: need for new strategies. Eur J Clin Nutr 68, 859–860 (2014). https://doi.org/10.1038/ejcn.2014.72

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2014.72

This article is cited by

Search

Advanced search

Quick links